Everyone's talking about empagliflozin

Maria Veiga-da-Cunha, Claudia Soler-Alfonso and Sarah Grünert join the podcast to talk about Empagliflozin, a repurposed drug with impressive efficacy in GSD 1b and G6PC3 deficiency. Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5 Cécile Boulanger, et al https://doi.org/10.1002/jimd.12509 Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment Eran Tallis, et al https://doi.org/10.1002/jmd2.12304 Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib Sarah Catharina Grünert, et al https://doi.org/10.1002/jmd2.12295